CA2889592A1 - Process for preparing bile acid derivatives - Google Patents

Process for preparing bile acid derivatives Download PDF

Info

Publication number
CA2889592A1
CA2889592A1 CA2889592A CA2889592A CA2889592A1 CA 2889592 A1 CA2889592 A1 CA 2889592A1 CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A1 CA2889592 A1 CA 2889592A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
preparing
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2889592A
Other languages
English (en)
French (fr)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of CA2889592A1 publication Critical patent/CA2889592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2889592A 2012-10-26 2013-10-25 Process for preparing bile acid derivatives Abandoned CA2889592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
US61/718,966 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CA2889592A1 true CA2889592A1 (en) 2014-05-01

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2889592A Abandoned CA2889592A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Country Status (22)

Country Link
US (2) US9777038B2 (enExample)
EP (1) EP2912013B1 (enExample)
JP (1) JP6272888B2 (enExample)
KR (1) KR102068381B1 (enExample)
CN (2) CN108250264A (enExample)
AU (1) AU2013334122B2 (enExample)
BR (1) BR112015009395A2 (enExample)
CA (1) CA2889592A1 (enExample)
CY (1) CY1119731T1 (enExample)
DK (1) DK2912013T3 (enExample)
ES (1) ES2655034T3 (enExample)
HK (1) HK1253301A1 (enExample)
HU (1) HUE036887T2 (enExample)
IL (1) IL238454B (enExample)
MX (1) MX361653B (enExample)
NO (1) NO2968302T3 (enExample)
NZ (2) NZ745013A (enExample)
PL (1) PL2912013T3 (enExample)
PT (1) PT2912013T (enExample)
SG (1) SG11201503247UA (enExample)
SM (1) SMT201700602T1 (enExample)
WO (1) WO2014066819A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013334122B2 (en) 2012-10-26 2017-11-02 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives
US10407462B2 (en) 2014-05-29 2019-09-10 Bar Pharmaceuticals S.R.L. Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases
US10131688B2 (en) 2014-11-19 2018-11-20 NZP UK Limited 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal FXR modulators
US10538550B2 (en) 2014-11-19 2020-01-21 NZP UK Limited 6.alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal FXR modulators
KR102526631B1 (ko) 2014-11-19 2023-04-27 엔제트피 유케이 리미티드 스테로이드 fxr 조절인자를 제조하기 위한 중간체로서의 6-알킬-7-하이드록시-4-엔-3-온 스테로이드
TWI688571B (zh) 2014-11-19 2020-03-21 英商Nzp英國有限公司 化合物(四)
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
EA036404B1 (ru) 2015-02-06 2020-11-06 Интерсепт Фармасьютикалз, Инк. Фармацевтические композиции для комбинированной терапии
EP3353189A4 (en) * 2015-09-24 2019-06-19 Intercept Pharmaceuticals, Inc. METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF GALLENIC ACID DERIVATIVES
MX2018005520A (es) * 2015-11-06 2018-08-01 Intercept Pharmaceuticals Inc Metodos para preparacion de acido obeticolico y derivados de los mismos.
WO2017142895A1 (en) * 2016-02-15 2017-08-24 Regents Of The University Of Minnesota Compositions and methods for treating clostridium associated diseases
WO2017180577A1 (en) 2016-04-13 2017-10-19 Intercept Pharmaceuticals, Inc. Methods of treating cancer
TW201738254A (zh) 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
CA3038534A1 (en) * 2016-09-30 2018-04-05 Intercept Pharmaceuticals, Inc. Crystalline forms of a bile acid derivative
WO2019023103A1 (en) 2017-07-24 2019-01-31 Intercept Pharmaceuticals, Inc. BILIARY ACID DERIVATIVES WITH ISOTOPIC MARKING
US11059854B2 (en) * 2017-07-26 2021-07-13 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Method for preparing steroid derivative FXR agonist
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
SG11202113155XA (en) 2019-05-30 2021-12-30 Intercept Pharmaceuticals Inc Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
US20230331766A1 (en) 2020-09-18 2023-10-19 Seoul National University R&Db Foundation Method for mass-producing sodium taurodeoxycholate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
AU2002308295B2 (en) 2001-03-12 2007-08-23 Intercept Pharmaceuticals, Inc. Steroids as agonists for FXR
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
PT2040713E (pt) * 2006-06-27 2014-10-13 Intercept Pharmaceuticals Inc Para a prevenção ou o tratamento de doenças ou estados clínicos mediados por fxr
US9943614B2 (en) * 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
EA020310B1 (ru) * 2008-07-30 2014-10-30 Интерсепт Фармасьютикалз, Инк. Модуляторы рецептора tgr5 и их применение
CN102282157B (zh) * 2008-11-19 2017-02-22 英特塞普特医药品公司 G蛋白偶联受体5(tgr5)调节剂及其使用方法
AU2013334122B2 (en) 2012-10-26 2017-11-02 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
NZ707389A (en) 2018-08-31
US10202414B2 (en) 2019-02-12
CN108250264A (zh) 2018-07-06
IL238454B (en) 2018-11-29
EP2912013A4 (en) 2016-06-01
KR20150074062A (ko) 2015-07-01
SG11201503247UA (en) 2015-06-29
IL238454A0 (en) 2015-06-30
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
WO2014066819A1 (en) 2014-05-01
EP2912013B1 (en) 2017-10-11
KR102068381B1 (ko) 2020-01-20
AU2013334122B2 (en) 2017-11-02
US9777038B2 (en) 2017-10-03
SMT201700602T1 (it) 2018-03-08
CY1119731T1 (el) 2018-06-27
PT2912013T (pt) 2018-01-03
DK2912013T3 (en) 2018-01-15
BR112015009395A2 (pt) 2017-07-04
CN105102425B (zh) 2018-04-10
ES2655034T3 (es) 2018-02-16
JP2015533852A (ja) 2015-11-26
JP6272888B2 (ja) 2018-01-31
AU2013334122A1 (en) 2015-05-14
CN105102425A (zh) 2015-11-25
NO2968302T3 (enExample) 2018-02-03
MX361653B (es) 2018-12-13
US20180079776A1 (en) 2018-03-22
MX2015005286A (es) 2015-10-29
EP2912013A1 (en) 2015-09-02
PL2912013T3 (pl) 2018-05-30
US20150291653A1 (en) 2015-10-15
HK1253301A1 (zh) 2019-06-14
NZ745013A (en) 2019-08-30

Similar Documents

Publication Publication Date Title
CA2889592A1 (en) Process for preparing bile acid derivatives
KR100555970B1 (ko) 2-아미노-1,3-프로판디올유도체의 제조방법
RU2624007C2 (ru) Способ получения улипристала ацетата и его промежуточных продуктов
JP2635213B2 (ja) 化学工程
JP5717752B2 (ja) ピリピロペン誘導体の製造法
PL200165B1 (pl) Sposób wytwarzania estrów nitroksyalkilowych naproksenu oraz ester nitroksybutylowy kwasu 2-(S)-(6-metoksy-2-naftylo)propanowego o wysokim nadmiarze enancjomerycznym
PL130559B1 (en) Process for preparing pure isosorbite 5-nitrate
US3538120A (en) Cyclopentyl-alkanoic acids
KR20090066910A (ko) L-3-o-치환-아스코르브산의 개선된 제조방법
DK170233B1 (da) Fremgangsmåde til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
EP0243646B1 (en) A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein
CN109134577B (zh) 一种3α-羟基-5α-胆烷酸的合成方法
AU2006272420A1 (en) Method for producing nebivolol
JP2024523040A (ja) ハイブチミブ中間体およびその調製法
US5072008A (en) Manufacture of lactol derivatives
PL243187B1 (pl) Sposób i związki pośrednie do otrzymywania menachinonu MK-7
HK1214239B (en) Process for preparing bile acid derivatives
US4906759A (en) Process for the production of 4-alkoxy-2(5H) thiophenones
Beccalli et al. 4-Azidotetronic Acids: A New Class of Azido Derivatives
JP2005314260A (ja) フラボンc配糖体の製法
CN101575287B (zh) 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
Yamagata et al. Rhodium (II) acetate‐catalyzed reaction of 2‐amino‐4, 5‐dihydro‐3‐furancarbonitriles with dialkyl diazomalonates
Ye et al. Expedient Construction of the Ziegler Intermediate Useful for the Synthesis of Forskolin via Consecutive Rearrangements
Yan-fen et al. Total Synthesis of Anisodine
PL197215B1 (pl) Nowy chiralny bromospirolakton karanu i sposób jego wytwarzania

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180705

FZDE Discontinued

Effective date: 20220502